Vet Practice Profitability Calculator

Most practice owners have a rough sense of their collections but no clear picture of their normalized EBITDA — the number that drives every serious valuation, whether you're evaluating a corporate offer, planning an associate buy-in, or modeling your retirement exit. This calculator takes your actual revenue and cost categories, benchmarks each line against AVMA industry averages, and shows you a realistic valuation range.

Use it to spot overhead leaks before a sale, understand how each dollar of EBITDA translates into deal value, and frame your numbers before engaging a broker or talking to Mars, NVA, or MVP.

Practice Revenue

Annual gross collections / revenue ($)

Full-time equivalent doctors (including owner)

Operating Expenses

Use your most recent full fiscal year or trailing 12 months. Leave a field at zero if the category doesn't apply.

COGS: drugs, vaccines, supplies, reference lab ($)

Staff wages + benefits (non-doctor employees only) ($)

Facility: rent or mortgage P&I, utilities ($)

Equipment payments, maintenance, marketing, software, insurance, misc ($)

Owner Doctor Compensation

Buyers normalize owner compensation against market-rate DVM cost (~$150K–$175K/FTE). Enter what the practice actually pays you, then list personal perks run through the business that a buyer would add back.

Owner W-2 salary or guaranteed draw ($/year)

Personal add-backs: 401k contributions, health insurance, vehicle, one-time items ($/year)

Line item	% of revenue	AVMA benchmark
Gross revenue	100%	—
COGS (drugs, supplies, lab)		20–25%
Staff wages + benefits		40–43%
Facility costs		5–6%
Equipment + other overhead		5–10%
Owner W-2 salary		—
EBITDA (before add-backs)		15–25%
Add-backs (perks, 401k, one-time items)		—
Adjusted EBITDA (seller's basis)		—

Exit path	EBITDA multiple	Estimated range
Private buyer (associate buy-in or independent investor)	4–6×
Corporate consolidator (Mars, NVA, MVP, VCA)	8–14×
Collections-based sanity check (70–95% of revenue)	—

How normalized EBITDA works

EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is the primary metric buyers use to value veterinary practices. Before a buyer applies their multiple, they normalize two key items:

Owner compensation. Buyers replace your W-2 with the cost of hiring a DVM at market rate. If your salary is $180K and the market rate for a full-time associate DVM in your area is $155K, they add back $25K. If your salary is below market, they subtract the difference. This normalization can move your effective EBITDA by $30–60K, which at a 10× corporate multiple is $300K–$600K in deal value.
Add-backs. Buyers accept one-time or discretionary owner expenses as add-backs: a vehicle used primarily personally, a family member on payroll who won't stay post-close, above-market rent paid to a related-party landlord. Recurring business expenses are not add-backs. Document each add-back — contested add-backs are the most common deal friction point in vet practice sales.

Overhead benchmarks by category

Category	Target range	Warning zone	Common root cause
COGS (drugs, supplies, lab)	20–25% of revenue	>28%: margin leak from inventory waste, under-charged dispensing fees, or over-reliance on reference lab	Formulary review, dispensing fee audit, in-house vs. reference lab economics
Staff wages + benefits	40–43% of revenue	>46%: over-staffed relative to revenue, or below-market fee schedule	Revenue per appointment analysis; schedule density; fee schedule benchmarking
Facility costs	5–6% of revenue	>8%: rent is high relative to revenue, or the practice is under-producing for its footprint	Revenue ramp-up plan; lease renegotiation on renewal; sub-specialty use of unused space
EBITDA margin	15–25%	<12%: limited buyer interest at market multiples; >30%: exceptional — confirm sustainable	Staff and COGS are the two highest-leverage levers; a 3-point margin improvement on $1.2M revenue = $36K more EBITDA = $360K more deal value at 10×

Source: AVMA Economic Research, Financial & Production Statistics annual surveys. Practice-type variation applies: emergency/specialty practices often run lower COGS but higher staff costs; rural mixed practices may have wider COGS ranges.

Private vs. corporate exit: what drives the multiple

Private buyer (4–6×)

Associate buy-in or individual investor
Funded via SBA 7(a) loan (max 90% financing)
Buyer's ability to service debt constrains the price
More flexible on deal structure; seller note common
No mandatory employment period after close

Corporate consolidator (8–14×)

Mars, NVA, MVP, VCA, Pathway Vet Alliance
Higher multiple but 20–30% is often equity rollover (illiquid)
Earnout ties 1–3 years of payment to EBITDA targets
3–5 year employment commitment as a condition of the deal
Minimum EBITDA threshold: most require ≥$200K adjusted EBITDA

The headline-multiple trap: A $2.4M valuation at 10× on $240K EBITDA looks great until you model the after-tax proceeds. Asset sales — the structure most buyers prefer — tax equipment recapture as ordinary income and goodwill at 20% federal long-term capital gains rate plus 3.8% NIIT. The spread between private and corporate multiples often narrows significantly after tax. Run the full tax model before evaluating any offer. See the vet practice sale tax guide for the complete breakdown.

What corporate buyers actually need to see

If a corporate offer is your goal, these are the factors that move the multiple:

Revenue threshold: Most corporate groups require ≥$1.0M in annual collections, and the best multiples (12×+) typically go to multi-doctor practices at $2M+.
EBITDA floor: Corporate acquirers typically require ≥$200K in adjusted EBITDA. Below that, they may still acquire but at a steep discount.
Growth trajectory: Year-over-year revenue growth of 5–10%+ is valued. A declining trend is a red flag even at high collections.
Staff stability: High DVM or technician turnover raises integration risk and lowers offered multiples. Buyers will review your retention metrics in due diligence.
Client metrics: Active client count, new client rate, and recheck compliance are increasingly part of corporate diligence — they signal organic growth potential.

Related tools and guides

Get your practice numbers reviewed

A fee-only advisor who specializes in veterinary practice finances can normalize your EBITDA, identify specific overhead leaks worth fixing before you list, model the after-tax proceeds of a private vs. corporate sale, and help you evaluate whether an offer is at, above, or below market. No commissions. No product sales.

Sources

AVMA Economic Research, Financial and Production Statistics — annual practice benchmarks used for overhead category ranges (staff, COGS, facility, EBITDA margin).
AVMA Veterinary Workforce Study — compensation and production data by practice type and specialty.
Simmons First Research Group, Veterinary Practice Market Report — private and corporate sale transaction data and EBITDA multiples.
SBA 7(a) loan program documentation — acquisition financing constraints used in private buyer multiple range rationale.

Overhead benchmarks based on AVMA data current through 2025. Valuation multiples represent typical market ranges as of 2025–2026; actual values depend on practice-specific factors including location, growth trajectory, staff stability, equipment condition, and acquirer appetite.

VetAdvisorMatch is a referral service, not a licensed advisory firm. We may receive compensation from professionals in our network. Content is for informational purposes only and does not constitute financial, tax, or investment advice.